Drug
Gepotidacin clinical trials
Also written GSK2140944.
Keep track of what changes. Save the gepotidacin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
23 studies that test it; most in 2014 (3)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 22 · Other 1
GlaxoSmithKline (22) · Institut National de la Santé Et de la Recherche Médicale, France (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses gepotidacin is read from its arms, and is right about nine times in ten.
Testing it · 23
- A Study to Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating WomenRecruitingPhase 1GlaxoSmithKlineNCT07645235Written as Gepotidacin
- A Study in Pediatric Participants Aged ≥2 to <12 Years With a Suspected or Confirmed Bacterial Infection or Receiving Prophylaxis AntibioticsNot yet recruitingPhase 1GlaxoSmithKlineNCT07371429Written as Gepotidacin
- A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis)CompletedPhase 3GlaxoSmithKlineNCT06597344Written as Gepotidacin
- A Study to Investigate the Efficacy and Safety With Gepotidacin in Japanese Female Participants With Uncomplicated Urinary Tract Infection (Acute Cystitis)CompletedPhase 3GlaxoSmithKlineNCT05630833Written as Gepotidacin
- Penetration of the Innovative Antibiotic Gepotidacin Into Prostate and Tonsillar TissueCompletedPhase 1Institut National de la Santé Et de la Recherche Médicale, FranceNCT04484740Written as Gepotidacin
- A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital GonorrheaCompletedPhase 3GlaxoSmithKlineNCT04010539Written as Gepotidacin
- Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI)CompletedPhase 3GlaxoSmithKlineNCT04187144Written as Gepotidacin
- A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI)CompletedPhase 3GlaxoSmithKlineNCT04020341Written as Gepotidacin
- A Study to Evaluate Pharmacokinetic, Safety, Tolerability and Relative Bioavailability of Gepotidacin in Healthy Adult Male and Female ParticipantsCompletedPhase 1GlaxoSmithKlineNCT05271799Written as Gepotidacin
- Drug-drug Interaction Study of GepotidacinCompletedPhase 1GlaxoSmithKlineNCT04493931Written as Gepotidacin
- Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic FunctionCompletedPhase 1GlaxoSmithKlineNCT03562117Written as Gepotidacin
- To Assess Bioavailability, Food Effect and Pharmacokinetics of Gepotidacin Tablets: A Phase I, Single-Dose, 2 Part Study in Healthy Subjects.CompletedPhase 1GlaxoSmithKlineNCT02853435Written as Gepotidacin Capsule
- Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents SubjectsCompletedPhase 1GlaxoSmithKlineNCT04079790Written as Gepotidacin
- Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal FunctionCompletedPhase 1GlaxoSmithKlineNCT02729038Written as Gepotidacin
- Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection (Acute Cystitis)CompletedPhase 2GlaxoSmithKlineNCT03568942Written as Gepotidacin
- Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure InfectionsCompletedPhase 2GlaxoSmithKlineNCT02045797Written as GSK2140944 Lyophile
- A Study to Investigate the Recovery, Excretion and Pharmacokinetics of [14C]-GSK2140944 Administered as a Single Intravenous and Single Oral Dose to Healthy Adult Male SubjectsCompletedPhase 1GlaxoSmithKlineNCT02000765Written as GSK2140944 for Injection
- Relative Bioavailability, Safety, Tolerability, Pharmacokinetics (PK) and Food Effect Study of GSK2140944 in Healthy SubjectsCompletedPhase 1GlaxoSmithKlineNCT02045849Written as GSK2140944 capsule
- Placebo and Moxifloxacin Controlled Cardiac Conduction Study of GSK2140944 in Healthy VolunteersCompletedPhase 1GlaxoSmithKlineNCT02257398Written as GSK2140944
- A Single Oral Escalating Dose Study of GSK2140944 in Healthy VolunteersCompletedPhase 1GlaxoSmithKlineNCT02202187Written as GSK2140944
Codes
What other systems call gepotidacin · ClinicalTrials.gg INT000568
- MeSH (NLM) C000612856gepotidacinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) DVF0PR037DGEPOTIDACINConfirmed FDA, NLM, Wikidata
- Wikidata Q19597285gepotidacinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C170025GepotidacinOne source FDA
- DrugBank DB12134One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000612856 | gepotidacin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | DVF0PR037D | GEPOTIDACIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q19597285 | gepotidacin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C170025 | Gepotidacin | One source FDA |
| DrugBank | DB12134 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.